Phase III randomized control study evaluating adjuvant metronomic chemotherapy in locally advanced head and neck cancers post-radical chemoradiation (MACE-CTRT).

被引：0
|
作者：
Chopade, Sunil Ramdhan
Patil, Vijay Maruti
Noronha, Vanita
Menon, Nandini Sharrel
Bhattacharjee, Atanu
Nawale, Kavita Prakash
Banavali, Shripad Dinanath
Prabhash, Kumar
Mathrudev, Vijayalakshmi
机构：
[1] Tata Mem, Mumbai, India
[2] Tata Mem Hosp, Mumbai, India
[3] Tata Mem Hosp, Mumbai, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6073
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)
    Pirus Ghadjar
    Stefanie Hayoz
    Frank Zimmermann
    Stephan Bodis
    David Kaul
    Harun Badakhshi
    Jacques Bernier
    Gabriela Studer
    Ludwig Plasswilm
    Volker Budach
    Daniel M Aebersold
    [J]. Radiation Oncology, 10
  • [22] Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)
    Ghadjar, Pirus
    Hayoz, Stefanie
    Zimmermann, Frank
    Bodis, Stephan
    Kaul, David
    Badakhshi, Harun
    Bernier, Jacques
    Studer, Gabriela
    Plasswilm, Ludwig
    Budach, Volker
    Aebersold, Daniel M.
    [J]. RADIATION ONCOLOGY, 2015, 10
  • [23] A phase III randomized trial of two cisplatin-based concurrent chemoradiation (CCRT) regimens for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
    Rodriguez, Cristina P.
    Adelstein, David J.
    Rybicki, Lisa A.
    Savvides, Panayiotis
    Saxton, Jerrold P.
    Koyfman, Shlomo A.
    Greskovich, John
    Yao, Min
    Scharpf, Joseph
    Lavertu, Pierre
    Wood, Benjamin J.
    Burkey, Brian
    Lorenz, Robert
    Rezaee, Rod
    Zender, Chad
    Ives, Denise I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [24] Adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The randomized phase III OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274).
    Mileshkin, Linda R.
    Moore, Kathleen N.
    Barnes, Elizabeth
    Gebski, Val
    Narayan, Kailash
    Bradshaw, Nathan
    Lee, Yeh Chen
    Diamante, Katrina
    Fyles, Anthony W.
    Small, William
    Gaffney, David K.
    Khaw, Pearly
    Brooks, Susan
    Thompson, J. Spencer
    Huh, Warner King
    Carlson, Matthew
    Mathews, Cara Amanda
    Rischin, Danny
    Stockler, Martin R.
    Monk, Bradley J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (18)
  • [25] Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: A randomized Phase III study
    Lewin, F
    Damber, L
    Jonsson, H
    Andersson, T
    Berthelsen, A
    Biorklund, A
    Blomqvist, E
    Evensen, JF
    Hansen, HS
    Hansen, O
    Jetlund, O
    Mercke, C
    Modig, H
    Overgaard, M
    Rosengren, B
    Tausjo, J
    Ringborg, U
    [J]. RADIOTHERAPY AND ONCOLOGY, 1997, 43 (01) : 23 - 28
  • [26] Radical treatment of locally advanced head and neck cancer with concurrent chemo radiation-cisplatin versus carboplatin: A randomized comparative phase III trial
    Dutta, Shatarupa
    Ghorai, Suman
    Choudhury, Krishnangshu B.
    Majumder, Anup
    [J]. CLINICAL CANCER INVESTIGATION JOURNAL, 2013, 2 (02): : 122 - 127
  • [27] Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study
    Ferrandina, Gabriella
    Palluzzi, Eleonora
    Gallotta, Valerio
    Gambacorta, Maria Antonietta
    Autorino, Rosa
    Turco, Luigi Carlo
    Macchia, Gabriella
    Cosentino, Francesco
    Gui, Benedetta
    Mattoli, Maria Vittoria
    Ronzino, Graziana
    Valentini, Vincenzo
    Scambia, Giovanni
    [J]. EJSO, 2018, 44 (07): : 1062 - 1068
  • [28] Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
    Noronha, Vanita
    Joshi, Amit
    Patil, Vijay Maruti
    Agarwal, Jaiprakash
    Ghosh-Laskar, Sarbani
    Budrukkar, Ashwini
    Murthy, Vedang
    Gupta, Tejpal
    D'Cruz, Anil K.
    Banavali, Shripad
    Pai, Prathamesh S.
    Chaturvedi, Pankaj
    Chaukar, Devendra
    Pande, Nikhil
    Chandrasekharan, Arun
    Talreja, Vikas
    Vallathol, Dilip Harindran
    Mathrudev, Vijayalakshmi
    Manjrekar, Aparna
    Maske, Kamesh
    Bhelekar, Arati Sanjay
    Nawale, Kavita
    Kannan, Sadhana
    Gota, Vikram
    Bhattacharjee, Atanu
    Kane, Shubhada
    Juvekar, Shashikant L.
    Prabhash, Kumar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (11) : 1064 - +
  • [29] Physical examination during chemoradiation predicts outcome of locally advanced head and neck cancer. Secondary results of a randomized phase III trial (SAKK 10/94)
    Ghadjar, Pirus
    Sun, Hong
    Zimmermann, Frank
    Bodis, Stephan
    Bernier, Jacques
    Studer, Gabriela
    Aebersold, Daniel M.
    [J]. ORAL ONCOLOGY, 2013, 49 (10) : 1006 - 1009
  • [30] Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: Impact of changing disease epidemiology on contemporary trial design
    Rodriguez, Cristina P.
    Adelstein, David J.
    Rybicki, Lisa A.
    Savvides, Panayiotis
    Saxton, Jerrold P.
    Koyfman, Shlomo A.
    Greskovich, John F.
    Yao, Min
    Scharpf, Joseph
    Lavertu, Pierre
    Wood, Benjamin G.
    Burkey, Brian B.
    Lorenz, Robert R.
    Rezaee, Rod P.
    Zender, Chad A.
    Ives, Denise I.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (11): : 1583 - 1589
12345